Next Article in Journal
Simultaneous Estimation of Amlodipine Besylate and Indapamide in a Pharmaceutical Formulation by a High Performance Liquid Chromatographic (RP-HPLC) Method
Previous Article in Journal
Improvement of the Prediction Power of the CoMFA and CoMSIA Models on Histamine H3 Antagonists by Different Variable Selection Methods
 
 
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Development and Validation of a Stability-Indicating RP-HPLC Method for the Quantitative Analysis of Anagrelide Hydrochloride

by
Sudhakar S. PUJERI
1,
Addagadde M. A. KHADER
1 and
Jaldappagari SEETHARAMAPPA
2,*
1
Department of Chemistry, Mangalore University, Mangalagangotri, India
2
Department of Chemistry, Karnatak University, Dharwad, India
*
Author to whom correspondence should be addressed.
Submission received: 29 December 2011 / Accepted: 16 April 2012 / Published: 16 April 2012

Abstract

A simple, rapid, and stability-indicating reverse-phase liquid chromatographic assay method was developed for Anagrelide Hydrochloride (ANG) in the presence of its degradation products generated from forced decomposition studies. The HPLC separation was achieved on a C18 Inertsil column (250 mm x 4.6 mm i.d. particle size is 5 μm), using solution A, a mixture of 0.03 M potassium di-hydrogen phosphate pH-adjusted to 3.0 using ortho-phosphoric acid (buffer): methanol: acetonitrile (90:5:5, v/v/v), and solution B, which contains a mixture of buffer: acetonitrile (10:90, v/v). The UV detector was operated at 251 nm while column temperature was maintained at 40°C, and the gradient program had the flow rate of 1.0 mL min−1. The developed method was validated as per ICH guidelines with respect to specificity, linearity, precision, accuracy, robustness, and limit of quantification. The method was found to be simple, specific, precise, accurate, and reproducible. Selectivity was validated by subjecting the stock solution of ANG to acidic, basic, photolysis, oxidative, and thermal degradation. The calibration curve was found to be linear in the concentration range of 0.05–152 μg mL−1 (R2 = 0.9991). The peaks of degradation products did not interfere with that of pure ANG. The utility of the developed method was examined by analyzing the tablets containing ANG.
Keywords: Anagrelide; Stability-indicating; Reverse phase; Validation; Forced degradation Anagrelide; Stability-indicating; Reverse phase; Validation; Forced degradation

Share and Cite

MDPI and ACS Style

PUJERI, S.S.; KHADER, A.M.A.; SEETHARAMAPPA, J. Development and Validation of a Stability-Indicating RP-HPLC Method for the Quantitative Analysis of Anagrelide Hydrochloride. Sci. Pharm. 2012, 80, 567-580. https://0-doi-org.brum.beds.ac.uk/10.3797/scipharm.1112-22

AMA Style

PUJERI SS, KHADER AMA, SEETHARAMAPPA J. Development and Validation of a Stability-Indicating RP-HPLC Method for the Quantitative Analysis of Anagrelide Hydrochloride. Scientia Pharmaceutica. 2012; 80(3):567-580. https://0-doi-org.brum.beds.ac.uk/10.3797/scipharm.1112-22

Chicago/Turabian Style

PUJERI, Sudhakar S., Addagadde M. A. KHADER, and Jaldappagari SEETHARAMAPPA. 2012. "Development and Validation of a Stability-Indicating RP-HPLC Method for the Quantitative Analysis of Anagrelide Hydrochloride" Scientia Pharmaceutica 80, no. 3: 567-580. https://0-doi-org.brum.beds.ac.uk/10.3797/scipharm.1112-22

Article Metrics

Back to TopTop